Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ABCG2 -- a transporter for all seasons.
Sarkadi B, Ozvegy-Laczka C, Német K, Váradi A. Sarkadi B, et al. Among authors: nemet k. FEBS Lett. 2004 Jun 1;567(1):116-20. doi: 10.1016/j.febslet.2004.03.123. FEBS Lett. 2004. PMID: 15165903 Free article. Review.
Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.
Ozvegy-Laczka C, Várady G, Köblös G, Ujhelly O, Cervenak J, Schuetz JD, Sorrentino BP, Koomen GJ, Váradi A, Német K, Sarkadi B. Ozvegy-Laczka C, et al. Among authors: nemet k. J Biol Chem. 2005 Feb 11;280(6):4219-27. doi: 10.1074/jbc.M411338200. Epub 2004 Nov 22. J Biol Chem. 2005. PMID: 15557326 Free article.
High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells.
Apáti A, Orbán TI, Varga N, Németh A, Schamberger A, Krizsik V, Erdélyi-Belle B, Homolya L, Várady G, Padányi R, Karászi E, Kemna EW, Német K, Sarkadi B. Apáti A, et al. Among authors: nemet k. Biochim Biophys Acta. 2008 Dec;1778(12):2700-9. doi: 10.1016/j.bbamem.2008.08.010. Epub 2008 Aug 20. Biochim Biophys Acta. 2008. PMID: 18793608 Free article.
Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: implications for the emergence and reversal of cancer drug resistance.
Hegedüs C, Truta-Feles K, Antalffy G, Várady G, Német K, Ozvegy-Laczka C, Kéri G, Orfi L, Szakács G, Settleman J, Váradi A, Sarkadi B. Hegedüs C, et al. Among authors: nemet k. Biochem Pharmacol. 2012 Aug 1;84(3):260-7. doi: 10.1016/j.bcp.2012.04.010. Epub 2012 Apr 21. Biochem Pharmacol. 2012. PMID: 22548830
43 results